🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

13 results for “Structure Therapeutics” Clear

  1. Aleniglipron

    Structure Therapeutics

    Obese

    phase 2 small molecule active

    1 trial

  2. Aleniglipron or Placebo

    Structure Therapeutics

    Obesity, Overweight, or Chronic Weight Management

    phase 2 small molecule active

    2 trials

  3. GPC-100

    Structure Therapeutics

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  4. GSBR-1290

    Structure Therapeutics

    Overweight or Obesity

    phase 2 small molecule completed

    1 trial

  5. TG-0054

    Structure Therapeutics

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  6. TG-0054 (2.24 mg/kg)

    Structure Therapeutics

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  7. TG-0054 combined with G-CSF

    Structure Therapeutics

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  8. aleniglipron or placebo

    Structure Therapeutics

    Obesity

    phase 2 small molecule completed

    1 trial

  9. A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C] GSBR-1290, in healthy participants

    Structure Therapeutics

    Not applicable - Healthy volonteers

    phase 1 other active

    1 trial

  10. GSBR-1290

    Structure Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. GSBR-1290 (Capsule/Tablet)

    Structure Therapeutics

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  12. TG-0054

    Structure Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  13. carotid-femoral pulse-wave velocity

    Structure Therapeutics

    Covid19

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources